granted
on 05 Apr 2024
Last Applicant/ Owned by
Route 206 & Province Line Road
Princeton
NJ
08543
Serial Number
90271685 filed on 22nd Oct 2020
Registration Number
N/A
Correspondent Address
Marilyn F. Kelly
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
The word(s) "JEQUED" has no meaning in a foreign language. Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejectioRead More
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for use in disease testing
No 90271685
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
06th Apr 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
05th Apr 2024 | SOU TEAS EXTENSION RECEIVED |
05th Apr 2024 | SOU EXTENSION 5 FILED |
05th Apr 2024 | SOU EXTENSION 5 GRANTED |
14th Oct 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
12th Oct 2023 | SOU TEAS EXTENSION RECEIVED |
12th Oct 2023 | SOU EXTENSION 4 FILED |
12th Oct 2023 | SOU EXTENSION 4 GRANTED |
02th Aug 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
02th Aug 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |